Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q43136715 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000113.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q43136715 | ||
| 024 | ‡a 0000-0002-1683-1314 ‡2 orcid | ||
| 024 | ‡a 36841708500 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q43136715 | ||
| 100 | 0 | ‡a Manuela Ferreira Almeida ‡9 ast ‡9 es ‡9 sl | |
| 375 | ‡a 2 ‡2 iso5218 | ||
| 400 | 0 | ‡a Manuela Ferreira Almeida ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Manuela Ferreira Almeida ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report | ||
| 670 | ‡a Author's Dietary management of urea cycle disorders: European practice. | ||
| 670 | ‡a Author's Dietary practices in isovaleric acidemia: A European survey | ||
| 670 | ‡a Author's Dietary practices in methylmalonic acidaemia: a European survey | ||
| 670 | ‡a Author's Dietary practices in propionic acidemia: A European survey | ||
| 670 | ‡a Author's Dietary practices in pyridoxine non-responsive homocystinuria: a European survey. | ||
| 670 | ‡a Author's Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome | ||
| 670 | ‡a Author's Early dietary treated patients with phenylketonuria can achieve normal growth and body composition | ||
| 670 | ‡a Author's Early feeding practices in infants with phenylketonuria across Europe | ||
| 670 | ‡a Author's Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels. | ||
| 670 | ‡a Author's Nutrition education tools used in phenylketonuria: clinician, parent and patient perspectives from three international surveys. | ||
| 670 | ‡a Author's Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source. | ||
| 670 | ‡a Author's Overweight and obesity in PKU: The results from 8 centres in Europe and Turkey | ||
| 670 | ‡a Author's Phenylketonuria: protein content and amino acids profile of dishes for phenylketonuric patients. The relevance of phenylalanine. | ||
| 670 | ‡a Author's Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach. | ||
| 670 | ‡a Author's Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile. | ||
| 670 | ‡a Author's Targeting specific nutrient deficiencies in protein-restricted diets: some practical facts in PKU dietary management | ||
| 670 | ‡a Author's The challenges of managing coexistent disorders with phenylketonuria: 30 cases. | ||
| 670 | ‡a Author's The correlation of genotype and phenotype in Portuguese hyperphenylalaninemic patients. | ||
| 670 | ‡a Author's The use of prealbumin concentration as a biomarker of nutritional status in treated phenylketonuric patients | ||
| 670 | ‡a Author's TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW | ||
| 909 | ‡a (orcid) 0000000216831314 ‡9 1 | ||
| 909 | ‡a (scopus) 36841708500 ‡9 1 | ||
| 919 | ‡a earlydietarytreatedpatientswithphenylketonuriacanachievenormalgrowthandbodycomposition ‡A Early dietary treated patients with phenylketonuria can achieve normal growth and body composition ‡9 1 | ||
| 919 | ‡a infantilerefsumdiseaseinfluenceofdietarytreatmentonplasmaphytanicacidlevels ‡A Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels. ‡9 1 | ||
| 919 | ‡a nutritioneducationtoolsusedinphenylketonuriaclinicianparentandpatientperspectivesfrom3internationalsurveys ‡A Nutrition education tools used in phenylketonuria: clinician, parent and patient perspectives from three international surveys. ‡9 1 | ||
| 919 | ‡a nutritionalstatusinpatientswithphenylketonuriausingglycomacropeptideastheirmajorproteinsource ‡A Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source. ‡9 1 | ||
| 919 | ‡a overweightandobesityinpkutheresultsfrom8centresineuropeandturkey ‡A Overweight and obesity in PKU: The results from 8 centres in Europe and Turkey ‡9 1 | ||
| 919 | ‡a phenylketonuriaproteincontentandaminoacidsprofileofdishesforphenylketonuricpatientstherelevanceofphenylalanine ‡A Phenylketonuria: protein content and amino acids profile of dishes for phenylketonuric patients. The relevance of phenylalanine. ‡9 1 | ||
| 919 | ‡a practicesinprescribingproteinsubstitutesforpkuineuropenouniformityofapproach ‡A Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach. ‡9 1 | ||
| 919 | ‡a speciallowproteinfoodsforphenylketonuriaavailabilityineuropeandanexaminationoftheirnutritionalprofile ‡A Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile. ‡9 1 | ||
| 919 | ‡a targetingspecificnutrientdeficienciesinproteinrestricteddietssomepracticalfactsinpkudietarymanagement ‡A Targeting specific nutrient deficiencies in protein-restricted diets: some practical facts in PKU dietary management ‡9 1 | ||
| 919 | ‡a challengesofmanagingcoexistentdisorderswithphenylketonuria30cases ‡A The challenges of managing coexistent disorders with phenylketonuria: 30 cases. ‡9 1 | ||
| 919 | ‡a correlationofgenotypeandphenotypeinportuguesehyperphenylalaninemicpatients ‡A The correlation of genotype and phenotype in Portuguese hyperphenylalaninemic patients. ‡9 1 | ||
| 919 | ‡a useofprealbuminconcentrationasabiomarkerofnutritionalstatusintreatedphenylketonuricpatients ‡A The use of prealbumin concentration as a biomarker of nutritional status in treated phenylketonuric patients ‡9 1 | ||
| 919 | ‡a tyrosinemiatype3acasereportofsiblingsandliteraturereview ‡A TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW ‡9 1 | ||
| 919 | ‡a earlyfeedingpracticesininfantswithphenylketonuriaacrosseurope ‡A Early feeding practices in infants with phenylketonuria across Europe ‡9 1 | ||
| 919 | ‡a dietarymanagementofmaternalphenylketonuriawithglycomacropeptideandaminoacidssupplementsacasereport ‡A Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report ‡9 1 | ||
| 919 | ‡a dietarymanagementofureacycledisorderseuropeanpractice ‡A Dietary management of urea cycle disorders: European practice. ‡9 1 | ||
| 919 | ‡a dietarypracticesinisovalericacidemiaaeuropeansurvey ‡A Dietary practices in isovaleric acidemia: A European survey ‡9 1 | ||
| 919 | ‡a dietarypracticesinmethylmalonicacidaemiaaeuropeansurvey ‡A Dietary practices in methylmalonic acidaemia: a European survey ‡9 1 | ||
| 919 | ‡a dietarypracticesinpropionicacidemiaaeuropeansurvey ‡A Dietary practices in propionic acidemia: A European survey ‡9 1 | ||
| 919 | ‡a dietarypracticesinpyridoxinenonresponsivehomocystinuriaaeuropeansurvey ‡A Dietary practices in pyridoxine non-responsive homocystinuria: a European survey. ‡9 1 | ||
| 919 | ‡a dietarytreatmentinphenylketonuriadoesnotleadtoincreasedriskofobesityormetabolicsyndrome ‡A Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome ‡9 1 | ||
| 946 | ‡a a ‡9 1 | ||
| 996 | ‡2 PTBNP|428370 | ||
| 996 | ‡2 ISNI|0000000070218225 | ||
| 996 | ‡2 PTBNP|1042912 | ||
| 996 | ‡2 ISNI|0000000067774837 | ||
| 996 | ‡2 PTBNP|1194093 | ||
| 996 | ‡2 ISNI|0000000068678038 | ||
| 996 | ‡2 PTBNP|199673 | ||
| 996 | ‡2 PTBNP|1056543 | ||
| 996 | ‡2 ISNI|0000000373584716 | ||
| 996 | ‡2 PTBNP|1215706 | ||
| 996 | ‡2 PTBNP|719950 | ||
| 996 | ‡2 ISNI|0000000104173644 | ||
| 996 | ‡2 ISNI|0000000077870021 | ||
| 996 | ‡2 PTBNP|965309 | ||
| 996 | ‡2 PTBNP|172659 | ||
| 996 | ‡2 ISNI|0000000069390685 | ||
| 996 | ‡2 PTBNP|253231 | ||
| 996 | ‡2 PTBNP|183227 | ||
| 996 | ‡2 PTBNP|1380854 | ||
| 996 | ‡2 LC|n 86070446 | ||
| 996 | ‡2 DNB|1157344887 | ||
| 996 | ‡2 PTBNP|1548430 | ||
| 996 | ‡2 ISNI|0000000358013480 | ||
| 996 | ‡2 PTBNP|1903161 | ||
| 996 | ‡2 PTBNP|189114 | ||
| 996 | ‡2 LC|n 94042165 | ||
| 996 | ‡2 ISNI|0000000069509850 | ||
| 996 | ‡2 PTBNP|246307 | ||
| 996 | ‡2 ISNI|0000000081559711 | ||
| 996 | ‡2 ISNI|0000000068108457 | ||
| 996 | ‡2 DNB|1206879831 | ||
| 996 | ‡2 ISNI|0000000067446999 | ||
| 996 | ‡2 ISNI|0000000444580350 | ||
| 996 | ‡2 PTBNP|2065 | ||
| 996 | ‡2 PTBNP|79906 | ||
| 996 | ‡2 PTBNP|197924 | ||
| 996 | ‡2 ISNI|0000000070828314 | ||
| 996 | ‡2 LIH|LNB:CX_q_E;=B_n_ | ||
| 996 | ‡2 PTBNP|798018 | ||
| 996 | ‡2 ISNI|0000000068313346 | ||
| 996 | ‡2 PTBNP|190548 | ||
| 996 | ‡2 ISNI|0000000070924824 | ||
| 996 | ‡2 ISNI|0000000069208353 | ||
| 996 | ‡2 PTBNP|237046 | ||
| 996 | ‡2 PTBNP|1400802 | ||
| 996 | ‡2 BLBNB|000618517 | ||
| 996 | ‡2 PTBNP|235801 | ||
| 996 | ‡2 ISNI|0000000070216289 | ||
| 996 | ‡2 LC|no 97012355 | ||
| 996 | ‡2 PTBNP|200358 | ||
| 996 | ‡2 ISNI|0000000070824145 | ||
| 996 | ‡2 ISNI|0000000069423301 | ||
| 996 | ‡2 PTBNP|212933 | ||
| 996 | ‡2 ISNI|0000000067996544 | ||
| 996 | ‡2 NTA|067936792 | ||
| 996 | ‡2 SUDOC|13346542X | ||
| 996 | ‡2 BIBSYS|4060456 | ||
| 996 | ‡2 PTBNP|29257 | ||
| 996 | ‡2 PTBNP|265206 | ||
| 996 | ‡2 ISNI|0000000068412600 | ||
| 996 | ‡2 ISNI|0000000070723248 | ||
| 996 | ‡2 PTBNP|281802 | ||
| 996 | ‡2 ISNI|0000000070530972 | ||
| 996 | ‡2 PTBNP|197603 | ||
| 996 | ‡2 RERO|A016244296 | ||
| 996 | ‡2 BLBNB|001558654 | ||
| 996 | ‡2 PTBNP|206313 | ||
| 996 | ‡2 PTBNP|2030 | ||
| 996 | ‡2 RERO|A020036342 | ||
| 996 | ‡2 PTBNP|1984 | ||
| 996 | ‡2 SUDOC|068669852 | ||
| 996 | ‡2 ISNI|0000000068081565 | ||
| 996 | ‡2 BLBNB|001129122 | ||
| 996 | ‡2 PTBNP|1988 | ||
| 996 | ‡2 ISNI|0000000373615877 | ||
| 996 | ‡2 SUDOC|153167165 | ||
| 996 | ‡2 BLBNB|000294135 | ||
| 996 | ‡2 ISNI|0000000068402162 | ||
| 996 | ‡2 BLBNB|000595419 | ||
| 996 | ‡2 PTBNP|1977 | ||
| 996 | ‡2 PTBNP|716842 | ||
| 996 | ‡2 BIBSYS|90925647 | ||
| 996 | ‡2 ISNI|0000000068086585 | ||
| 996 | ‡2 PTBNP|1300656 | ||
| 996 | ‡2 ISNI|0000000043111537 | ||
| 996 | ‡2 ISNI|0000000373493566 | ||
| 996 | ‡2 BLBNB|000177321 | ||
| 996 | ‡2 DNB|1157196489 | ||
| 996 | ‡2 PTBNP|1721451 | ||
| 996 | ‡2 ISNI|0000000070022417 | ||
| 996 | ‡2 ISNI|000000010885026X | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
